A phase Ib, open‐label, single arm study to assess the safety, pharmacokinetics, and impact on humoral sensitization of SANGUINATE infusion in patients with end‐stage renal disease
Bassam G. Abu Jawdeh; Ervin Steve Woodle; Abbie D. Leino; Paul Brailey; Simon Tremblay; Tonya Dorst; Mouhamad H. Abdallah; Amit Govil; Daniel Byczkowski; Hemant Misra; Abraham Abuchowski; Rita R. Alloway
Author Information: Division of Nephrology
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.